Alpha Teknova, Inc. - stock earnings
TKNO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -10.7 million USD | 7.9 million USD |
| 2023Q3 | -10.2 million USD | 8.2 million USD |
| 2023Q2 | -7.2 million USD | 11.5 million USD |
| 2023Q1 | -8.8 million USD | 9.1 million USD |
| 2022Q4 | -13.3 million USD | 7.9 million USD |
| 2022Q3 | -22.5 million USD | 10.7 million USD |
| 2022Q2 | -6.2 million USD | 11.7 million USD |
| 2022Q1 | -5.5 million USD | 11.1 million USD |
| 2021Q4 | -3.6 million USD | 10.1 million USD |
| 2021Q3 | -3.3 million USD | 9.4 million USD |
| 2021Q2 | -2.3 million USD | 8.3 million USD |
| 2021Q1 | -655000 USD | 9.1 million USD |
| 2020Q4 | 577000 USD | 10.2 million USD |
| 2020Q3 | 1.5 million USD | 9.0 million USD |
| 2020Q2 | 512000 USD | 6.0 million USD |
| 2020Q1 | 948000 USD | 6.1 million USD |
TKNO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -36.8 million USD | 36.7 million USD |
| 2022 | -47.5 million USD | 41.4 million USD |
| 2021 | -9.8 million USD | 36.9 million USD |
| 2020 | 3.6 million USD | 31.3 million USD |
| 2019 | -1.3 million USD | 20.1 million USD |
TKNO
Price: $1.98
52 week price:
Earnings Per Share: -1.38 USD
P/E Ratio: -2.55
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 32300
Market Capitalization: 104.6 million